Author: Fiona Craig

Landmark T-Rex Leather Creation Fails to Meet Auction Reserve

BSF Enterprise PLC (LSE:BSFA) has announced that the first commercial product created using its T-Rex Leather™ technology, a museum-grade luxury handbag developed in collaboration with avant-garde fashion house Enfin Levé, attracted significant international attention at a Paris auction but remained unsold after failing to reach its reserve price.

Following the auction, the company withdrew the handbag from public sale and is now exploring a private transaction with a select group of high-net-worth collectors and institutions. Management believes this approach may better reflect what it considers to be the item’s unique historical, artistic and technological significance.

Global Exposure Raises Profile of Bio-Leather Platform

Although the auction did not result in a sale, BSF said the project generated substantial media coverage and public engagement through exhibitions and promotional events over the past two months.

The exposure has helped increase awareness of the company’s Lab-Grown Leather (LGL) platform and its potential applications across luxury goods, fashion and advanced materials sectors.

Management noted that interest from corporate partners has remained strong despite the auction outcome, highlighting growing recognition of bio-engineered alternatives to traditional leather products.

Commercial Discussions Progress Across Multiple Industries

BSF revealed that it is continuing research and technical discussions with a major global sportswear company and a leading automotive manufacturer.

Both organisations are evaluating the material’s structural characteristics, scalability and intellectual property advantages to determine its suitability for commercial applications. Potential uses include high-performance footwear, premium sportswear products and bespoke vehicle interiors.

The company believes these discussions demonstrate the broader commercial potential of its bio-synthetic leather technology beyond luxury accessories.

Financial Challenges Offset by Strategic Progress

While BSF continues to advance its commercialisation efforts, the company’s outlook remains influenced by ongoing losses and continued cash consumption.

These challenges are partially balanced by improving revenues and the benefit of a debt-free balance sheet. Technical indicators have also remained relatively supportive, with the share price trading above key moving averages and supported by a positive MACD reading.

However, valuation metrics remain constrained by negative earnings and the absence of dividend support.

More About BSF Enterprise

BSF Enterprise PLC is an investment company focused on developing and commercialising next-generation bio-sustainable technologies. Through its Lab-Grown Leather (LGL) platform, the company is working to create bio-synthetic structural leather products for use across luxury fashion, accessories, sportswear, performance footwear and automotive interiors.

Its strategy centres on supporting innovative technologies that combine sustainability, advanced materials science and commercial scalability, targeting sectors where demand for environmentally responsible alternatives continues to grow.

Pennsylvania Distribution Centre Successfully Subleased

Debenhams Group (LSE:DEBS) has completed the subletting of its 1.1 million square foot distribution facility in Elizabethtown, Pennsylvania, to international third-party logistics provider ID Logistics.

The warehouse became surplus to requirements after the company ceased operations at the site in November 2024 and transferred fulfilment of U.S. customer orders back to its UK-based distribution network.

The facility carried approximately 8.5 years of remaining lease commitments and had already generated around $124 million of cumulative costs through rent, operating expenses and capital investment.

Deal Significantly Reduces Future Cost Burden

The sublease agreement extends through to the expiry of the original lease term, allowing Debenhams Group to substantially reduce its future obligations associated with the property.

Management estimates the transaction will eliminate approximately $100 million of future lease and holding costs, representing a significant step in reducing the company’s fixed-cost base.

The agreement forms part of the group’s broader strategy to simplify operations and move towards a more asset-light business model.

Financial Benefits Expected Over Coming Years

As a result of the transaction, Debenhams expects to recognise an estimated non-cash exceptional credit of around £40 million.

The agreement is also forecast to reduce annual lease-related costs from approximately £13 million in the current financial year to around £8 million in FY28 and £6 million in FY29.

Management believes these savings will improve financial flexibility and support ongoing efforts to strengthen the group’s operating performance.

Turnaround Strategy Continues Amid Challenging Conditions

The sublease marks another step in Debenhams Group’s restructuring programme as it seeks to improve efficiency and streamline operations.

However, the company’s outlook remains challenged by a combination of declining revenues, ongoing losses, elevated leverage and negative operating cash flow. Technical indicators also remain weak, with the share price trading below key moving averages despite some signs that the stock may be oversold.

Valuation metrics provide limited support, as the company remains loss-making and does not currently offer a dividend yield.

More About Debenhams Group

Debenhams Group, part of boohoo group plc, operates a portfolio of online fashion, beauty and homeware brands serving millions of customers across multiple markets. Its portfolio includes Debenhams, Karen Millen, boohoo, MAN and PrettyLittleThing.

Originally founded in 1778, Debenhams has evolved from a traditional department store chain into a digital retail platform, positioning itself as Britain’s online department store while pursuing a marketplace-led growth strategy focused on fashion and lifestyle products.

Cost Inflation Prompts Profit Guidance Revision

McBride (LSE:MCB) has reduced its profit outlook after warning that higher raw material and energy costs are expected to place pressure on earnings over the coming year.

The company said inflation affecting petrochemical-based materials and energy-intensive inputs has been exacerbated by ongoing tensions in the Middle East. While McBride is implementing price increases for customers, these measures are expected to lag behind the pace of cost inflation, creating a temporary squeeze on margins.

As a result, the group now expects adjusted EBITA for both fiscal 2026 and fiscal 2027 to come in between 5% and 10% below current analyst forecasts.

Margin Pressure Expected to Peak in Coming Quarters

Management anticipates that the majority of the financial impact will be felt during the fourth quarter of fiscal 2026 and the first quarter of fiscal 2027.

The company expects trading conditions to improve thereafter, with profitability forecast to normalise from the second quarter of fiscal 2027 as pricing actions take effect and cost pressures begin to ease.

Despite the near-term challenges, McBride believes the underlying market environment remains supportive.

Private-Label Demand Remains Resilient

The group noted that demand for private-label household cleaning products continues to hold up well as consumers increasingly seek value-oriented alternatives amid broader inflationary pressures.

This trend has helped support volumes across McBride’s product categories and reinforces the company’s position as a key supplier to retailers and brand owners across Europe.

Management believes the ongoing shift towards private-label products could continue to provide a favourable backdrop for the business despite short-term margin challenges.

Eurotab Acquisition Remains on Track

McBride also confirmed that it remains on course to complete the acquisition of Eurotop’s Eurotab Group around 1 July 2026.

The transaction is expected to strengthen the company’s position in the European unit dosing detergent market by adding scale, expanding capabilities and enhancing its competitive standing within the private-label cleaning sector.

The group views the acquisition as a strategically important step that will support long-term growth despite current market headwinds.

Valuation and Cash Generation Provide Support

McBride’s investment case continues to benefit from an attractive valuation profile, including a relatively low price-to-earnings ratio and dividend support.

While profitability remains constrained by thin margins, uneven revenue growth and elevated leverage, these factors have been partially offset by improved cash generation. Technical indicators currently suggest a neutral market outlook, offering no strong directional signal in the near term.

Recent management commentary has remained broadly constructive, highlighting strong cash flow performance while noting manageable challenges related to SAP implementation and foreign exchange movements.

More About McBride

McBride plc is one of Europe’s largest manufacturers of private-label and contract-manufactured cleaning and hygiene products for household and professional use. The company supplies retailers and brand owners across the continent, specialising in value-focused cleaning solutions and holding a strong market position in unit dosing detergents. McBride benefits from long-term consumer demand for affordable private-label alternatives and continues to expand its capabilities through strategic acquisitions and operational investments.

Utah Pilot Project Advances Toward Commissioning

Quadrise Plc (LSE:QED) has provided an update on its collaboration with Valkor Technologies in Utah, reporting continued progress on preparations for the companies’ upstream production project.

Quadrise said its equipment is ready for deployment, while representative heavy sweet crude oil samples have been produced at Valkor’s new pilot facility for use in MSAR and bioMSAR formulation and testing activities.

The update marks another step forward in the development programme, which is intended to demonstrate the commercial potential of Quadrise’s fuel technologies within the U.S. upstream energy market.

Pilot Plant Timeline Revised

Valkor’s 500-barrel-per-day oil sands pilot plant is now expected to enter commissioning during the fourth quarter of 2026.

As a result of the revised schedule, Quadrise has adjusted the planned delivery date for its 600-barrel-per-day Multifuel Manufacturing Unit (MMU), which is now expected to be delivered during the third quarter of 2026.

The company said the updated timeline is designed to align equipment deployment with the anticipated commissioning schedule for the pilot facility.

Outstanding Licence Fee Remains Under Review

Quadrise also provided an update regarding the licence fee associated with the Valkor project.

Of the US$1.0 million licence fee due under the agreement, US$0.95 million remains unpaid. The company noted that no additional payments have been received since late November 2025, with Valkor currently awaiting approval of project funding.

Despite the delay, the board said it expects the outstanding balance to be settled in full by 30 September 2026, reflecting continued confidence in the project’s progression and funding outlook.

Commercialisation Opportunity Balanced by Execution Risk

Management continues to view the Utah project as an important commercial opportunity for the deployment of its low-emission fuel technologies in North America.

However, the company’s outlook remains affected by weak financial metrics, including limited revenue generation, ongoing losses and increasing free cash flow consumption. Technical indicators also remain negative, with the share price trading below key moving averages and a bearish MACD reading.

These challenges are partially offset by a relatively low-debt balance sheet, defined commercialisation milestones and the prospect of near-term cash inflows from outstanding receivables. Nevertheless, execution and funding risks remain key factors for investors to monitor.

More About Quadrise

Quadrise Plc is a clean-energy technology company focused on reducing emissions in shipping and heavy industry through the development and commercialisation of alternative fuel solutions. The company’s proprietary MSAR and bioMSAR technologies are designed to provide lower-cost, lower-emission alternatives to conventional fuels for customers in the marine, power generation, industrial and refining sectors. Through its fuel emulsion technology, Quadrise aims to help customers lower greenhouse gas emissions while improving fuel efficiency and operating economics.

Strategic Agreement Targets Rapid Project Development

African Pioneer (LSE:AFP) has entered into a non-binding term sheet with Hong Kong-based Xinhai Mining Services aimed at accelerating the development of its Ongombo and Ongeama copper projects in Namibia.

The proposed partnership would see Xinhai provide a comprehensive package covering financing, engineering, construction and commissioning services, with the objective of bringing the projects into commercial copper production more quickly.

Both assets are located near Windhoek and form a key part of African Pioneer’s strategy to build a significant copper development business in the region.

Xinhai to Fund Development Milestones

Under the framework being discussed, Xinhai would finance 100% of the expenditure required to achieve agreed project development milestones.

If the arrangement proceeds as planned and performance targets are met, African Pioneer would not be required to raise additional capital to fund project development. The structure is intended to reduce financing risk while accelerating the transition from exploration to production.

Equity Participation Strengthens Long-Term Partnership

Subject to the completion of definitive agreements, Xinhai is expected to acquire a 10% equity stake in African Pioneer.

The proposed deal also includes a loan facility linked to a substantial interest in the project holding company, further aligning the interests of both parties and establishing a longer-term strategic relationship.

Management believes the partnership has the potential to significantly advance the company’s Namibian copper ambitions while supporting the country’s growing role as an emerging copper-producing jurisdiction.

Financial Challenges Remain Despite Positive Technical Signals

Although the proposed agreement represents a potentially transformative development opportunity, African Pioneer’s outlook continues to be affected by weak underlying financial performance.

The company remains loss-making and continues to report negative operating and free cash flow, although leverage levels remain relatively low. From a market perspective, technical indicators have been more encouraging, with the shares trading above key moving averages and supported by a positive MACD reading.

Valuation metrics remain constrained by negative earnings, resulting in a negative price-to-earnings ratio, while the absence of a dividend provides limited support for income-focused investors.

More About African Pioneer

African Pioneer PLC is a mineral exploration and resource development company focused primarily on copper opportunities across Namibia, Zambia and Botswana. The company is advancing a portfolio of projects located near established infrastructure, with a particular emphasis on Namibia, where it aims to develop high-quality copper assets capable of benefiting from rising global demand for the metal driven by electrification and energy transition trends.

New Health Positioned for Launch of Oral GLP-1 Therapy

MedPal AI (LSE:MPAL) believes its private weight-management platform, New Health, is well placed to benefit from the UK launch of the first oral GLP-1 receptor agonist approved for weight loss following an earlier-than-expected authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA).

The treatment is currently available only through private prescriptions, creating an opportunity for providers capable of delivering accessible and scalable weight-management services. MedPal AI expects growing interest from patients seeking an alternative to injectable therapies as New Health expands its national rollout.

Technology Platform Designed to Support Growing Demand

The company’s offering combines AI-powered patient triage, clinician supervision and automated pharmacy fulfilment to streamline the treatment pathway from consultation to prescription delivery.

Through this integrated model, MedPal AI aims to provide a convenient route for patients seeking weight-loss therapies while leveraging its digital healthcare infrastructure to manage increasing demand efficiently.

Management believes the availability of an oral treatment option could broaden the appeal of GLP-1 therapies among individuals who may be reluctant to use injectable medications.

U.S. Adoption Highlights Market Potential

The board has pointed to the strong commercial performance of oral semaglutide in the United States as an indicator of potential demand in the UK market.

According to the company, more than three million prescriptions have been issued in the U.S. within just over five months of launch, with many users being first-time GLP-1 patients. MedPal AI believes this trend demonstrates how tablet-based therapies can expand the addressable market beyond traditional injectable treatment users.

Private Market Opportunity Remains Significant

With NHS access not currently available and a formal evaluation by the National Institute for Health and Care Excellence (NICE) still pending, the company sees a substantial opportunity within the private healthcare sector.

Management believes this environment could strengthen New Health’s competitive position and support continued growth across MedPal AI’s broader digital healthcare and pharmacy operations as demand for weight-management treatments continues to increase.

More About MedPal AI

MedPal AI Plc is a UK-based digital health and pharmacy technology company developing the MedPal Health OS, an AI-driven healthcare platform that integrates wellness tools, clinician-led services and prescription fulfilment.

Through its subsidiary, MedPal Limited, the group operates a 24-hour AI-enabled pharmacy distribution centre that provides nationwide NHS and private prescription services. The business combines artificial intelligence, robotic dispensing technology and rapid delivery capabilities to create a fully integrated digital healthcare ecosystem.

Refinancing Strengthens Financial Flexibility

Severfield plc (LSE:SFR) has completed the refinancing of its principal borrowing facilities through a new three-year banking agreement with its existing syndicate of lenders.

The package includes the renewal of the group’s £60 million revolving credit facility, the continuation of its £7.6 million term loan through to December 2027 and the introduction of an accordion facility that could provide access to an additional £30 million if required.

Improved Terms Extend Debt Maturities

The unsecured refinancing arrangement extends the maturity profile of Severfield’s debt facilities to June 2029, with options available to further extend the agreement.

Management said the revised package has been secured on improved commercial terms, providing greater financial flexibility and reinforcing the company’s liquidity position as it continues to pursue operational and strategic objectives across its UK and European businesses.

The agreement also reflects continued support from the company’s lending partners and confidence in Severfield’s financial strength and market position.

Enhanced Liquidity Supports Growth Opportunities

The new facilities are designed to support day-to-day operations while providing additional capacity for investment and future growth initiatives.

With access to the expanded funding package, Severfield believes it is well positioned to pursue opportunities across its core markets while maintaining a disciplined approach to capital allocation and balance sheet management.

The additional flexibility could also help the group navigate changing market conditions while supporting long-term strategic development.

Market Challenges Continue to Influence Outlook

Despite the refinancing milestone, Severfield continues to operate in a challenging trading environment characterised by pressure on revenues and profitability.

While recent corporate developments and certain technical indicators have offered more positive signals, valuation metrics remain under pressure and liquidity considerations continue to be monitored by investors.

The company’s dividend yield remains a supportive factor, while the alignment of management incentives with shareholder interests is viewed as a positive element within the broader investment case.

More About Severfield

Severfield plc is one of the UK’s leading structural steel specialists, providing design, fabrication and construction services for steel superstructures. The group has annual production capacity of approximately 150,000 tonnes across six manufacturing facilities and employs around 1,800 people.

Its projects span a wide range of sectors, including industrial and logistics, commercial offices, data centres, retail, healthcare, education, transport, energy, nuclear and leisure developments. Severfield also maintains a presence in India through its joint venture with JSW Steel, supporting growth in one of the world’s largest infrastructure markets.

Landmark Year Marks Transition to AI-Focused Business

Pri0r1ty Intelligence Group PLC (LSE:PR1) has reported its first full-year results since completing its transition from a listed cash shell into an artificial intelligence-driven technology and services group and restoring trading of its shares on AIM.

During the period, the company completed the reverse acquisition of Pri0r1ty AI, acquired sports marketing specialist Halfspace and raised £1.8 million to support growth initiatives. The group also established a portfolio of businesses focused on delivering solutions across targeted sectors including sport, music, entertainment and lifestyle.

Revenue Growth Established Following Strategic Restructuring

For the year ended 30 September 2025, Pri0r1ty generated revenue of £174,174 and recorded gross profit of £133,511 as it began building its commercial operations following the transformation.

The company reported a pre-tax loss of £10.3 million, although the result was significantly influenced by a £7.0 million non-cash accounting charge associated with the reverse takeover process rather than underlying trading performance.

Management noted that the figures reflect a business still in the early stages of scaling its operations following a major corporate restructuring.

Client Wins and Product Expansion Support Growth Strategy

The group continued to build momentum throughout the year, securing contracts and relationships with organisations including Aston Villa FC and World Aquatics.

Pri0r1ty also expanded its product offering through the launch of Fan Sonar and Advisor 2.0, two AI-powered solutions designed to enhance customer engagement and business decision-making.

Alongside product development, the company strengthened its leadership team as it seeks to accelerate growth across its SaaS and data-driven marketing activities.

Early Signs of Commercial Momentum

Eight months into the current financial year, the group reported contracted revenue exceeding £0.4 million, providing evidence of growing market adoption of its services.

Management believes this progress demonstrates early traction for its strategy of delivering AI-powered software and marketing solutions to small and medium-sized enterprises on a global scale.

The company continues to focus on expanding recurring SaaS revenues while leveraging its sector expertise across sports, entertainment and lifestyle markets.

More About Pri0r1ty Intelligence Group

Pri0r1ty Intelligence Group PLC is a data, artificial intelligence and marketing services business focused on helping small and medium-sized enterprises accelerate growth. Through its Halfspace, Pri0r1ty and Metr1c divisions, the company provides AI-driven software solutions, data-led marketing services and commercial partnership strategies across the sports, music, entertainment and lifestyle sectors. Its long-term strategy centres on scaling AI-enabled SaaS products while building a diversified portfolio of specialist digital businesses.